8:00-8:30
Welcome address
Chairs: Christian Manegold (Mannheim, Germany), Jacek Niklinski (Bialystok, Poland), Saulius Cicenas (Vilnius, Lithuania)
1. Zivile Gudleviciene - Adviser to the Prime Minister on Healthcare and People with Disabilities
2. Algirdas Utkus - Dean of the Faculty of Medicine Vilnius University
3. Neringa Ciakiene - Director of Lithuanian Cancer Patients Coalition „POLA“ (Remotely)
4. Ernestas Janulionis - Director of National Cancer Institute
8:35-9:20
Epidemiology/Tobaco Control/Lung Cancer Screening
Chairs: Giedre Smailyte (Vilnius, Lithuania), Vaida Gedvilaite (Vilnius, Lithuania)
08:35-08:50
Epidemiology of lung cancer
Giedre Smailyte (Vilnius, Lithuania) Onsite
08:50-09:05
Lung cancer prevention in Bulgaria
Snegina Nedeva (Sofia, Bulgaria) Remotely
09:05-09:20
Lung Cancer screening: means to overcome current challenges
Wieland Voigt (Erlangen, Germany) Onsite
09:25-10:10
Pathology/ Molecular Diagnostics
Chairs: Kestutis Suziedelis (Vilnius, Lithuania), Jacek Niklinski (Bialystok, Poland)
09:25-09:40
Innovativ diagnostics for NSCLC and SCLC
Mauro Papotti (Torino, Italy) Remotely
09:40-09:55
Lung Cancer and Genomics - Where We are Now?
Marcin Moniuszko (Bialystok, Poland) Remotely
09:55-10:10
Evolution of genome editing and application in lung cancer
Kestutis Suziedelis (Vilnius, Lithuania) Onsite
10:15-11:15
Sattelite MSD
Chairs: Vaida Gedvilaite (Vilnius, Lithuania)
10:15-11:15
Experiences and new approaches to 1L IO-chemo treatment in metastatic NSCLC settings
Martin Reck (Grosshansdorf, Germany) Remotely
11:15-11:30
IO plus chemotherapy in metastatic NSCLC: NCI clinical cases
Vaida Gedvilaite (Vilnius, Lithuania) Onsite
11:45-12:30
Surgery for Lung Cancer
Chairs: Saulius Cicenas (Vilnius, Lithuania), Miroslaw Kozlowski (Bialystok, Poland)
11:45-12:00
Thoracic surgery in real oncological practice
Miroslaw Kozlowski (Bialystok, Poland) Onsite
12:00-12:15
The role of VATS in thoracic oncology
Aleksandras Bagajevas (Klaipeda, Lithuania), Paulius Radziminskas (Klaipeda, Lithuania) Onsite
12:15-12:30
Abliations of Malignant Lung Tumours
Sigitas Zaremba (Vilnius, Lithuania) Onsite
12:35-13:20
Sattelite AstraZeneca
Chairs: Saulius Cicenas (Vilnius, Lithuania)
12:20-12:50
Expectations for early diagnosis of lung cancer
Edvardas Danila (Vilnius, Lithuania) Onsite
12:50-13:20
ADAURA clinical trial overview
Marius Zemaitis (Kaunas, Lithuania) Remotely
14:25-15:10
Medical Management of Lung Cancer
Chairs: Jacek Niklinski (Bialystok, Poland), Edvardas Danila (Vilnius, Lithuania)
14:25-14:40
Novel therapies for SCLC
Sofia Baka (Athens, Greece) Remotely
14:40-14:55
Systemic therapy of operable NSCLC
Robert Pirker (Vienna, Austria) Onsite
14:55-15:10
Adjuvant targeted therapies for respectable NSCLC: current practice in China.
Xiaofei WANG (Shanghai, China) Remotely
15:15-15:45
Sattelite Pfizer
Chairs: Edvardas Danila (Vilnius, Lithuania)
15:15-15:45
Treatment sequencing for patients with ALK-positive non-small cell lung cancer (NSCLC). Presentation of a clinical case
Anastasija Ranceva (Vilnius, Lithuania) Remotely
15:50-16:20
Sattelite Roche
Chairs: Kestutis Suziedelis (Vilnius, Lithuania)
15:50-16:20
Comprehensive genomic profiling (CGP) in lung cancer - benefits for clinicians and patients
Marius Zemaitis (Kaunas, Lithuania) Remotely
16:30-17:15
Immuno-oncology and TKI inhibitors in Lung Cancer
Chairs: Christian Manegold (Mannheim, Germany), Lothar Richard Pilz (Mannheim, Germany)
16:30-16:45
Immune therapies in advanced NSCLC: current practice
Christian Manegold (Mannheim, Germany) Onsite
16:45-17:00
Preoperative immune therapies for resectable NSCLC: current practice in China
Huizhao HONG (Guangdong, China) Remotely
17:00-17:15
Immune therapies and targeted therapies for NSCLC: interpretation of clinical trials
Lothar Richard Pilz (Mannheim, Germany) Onsite
17:20-18:20
Young Investigators
Chairs: Jacek Niklinski (Bialystok, Poland), Saulius Cicenas (Vilnius, Lithuania)
17:20-17:35
Quality Standards in Biobanking for Research Excellence
Anna Michalska-Falkowska (Bialystok, Poland) Onsite
17:35-17:50
Application of Machine Learning Algorithms for analysis of large sets of biobanked data
Anna Michalska-Falkowska (Bialystok, Poland) Onsite
17:50-18:20
Evaluation of CD8+lymphocytes filtering non-small-cell lung cancer by immunohistochemistry results
Jaroslav Bublevic (Vilnius, Lithuania) Remotely
18:25
Closing Remarks
Chairs: Saulius Cicenas (Vilnius, Lithuania), Jacek Niklinski (Bialystok, Poland), Christian Manegold (Mannheim, Germany)